Search

Thermo Fisher Scientific Inc

Slēgts

SektorsVeselības aprūpe

627.16 -0.04

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

625.32

Max

629.32

Galvenie mērījumi

By Trading Economics

Ienākumi

85M

1.7B

Pārdošana

989M

12B

P/E

Sektora vidējais

31.649

57.371

EPS

6.03

Dividenžu ienesīgums

0.31

Peļņas marža

14.516

Darbinieki

125,000

EBITDA

262M

2.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

-1.89% downside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.31%

2.23%

Nākamie ieņēmumi

2026. g. 21. okt.

Nākamais dividenžu datums

2026. g. 15. okt.

Nākamais Ex dividenžu datums

2026. g. 15. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

21B

216B

Iepriekšējā atvēršanas cena

627.2

Iepriekšējā slēgšanas cena

627.16

Ziņu noskaņojums

By Acuity

21%

79%

65 / 340 Rangs Healthcare

Thermo Fisher Scientific Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 21. aug. 23:06 UTC

Thermo Fisher Scientific shares declined in after-market trading, despite overall market strength. The asset remains above its 20-day moving average.

2026. g. 20. aug. 20:02 UTC

Thermo Fisher Scientific Inc shares are higher, maintaining a positive trajectory since Wednesday despite overall market pressure from Walmart's disappointing earnings.

2026. g. 19. aug. 23:01 UTC

Thermo Fisher Scientific Inc shares are higher in after-market trading, nearing the upper end of their one-month range and above the 20-day moving average.

2026. g. 18. aug. 23:36 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours. Broader market dynamics include a decline in the Nikkei 225 Index and rising bond yields.

2026. g. 17. aug. 20:06 UTC

Correlated Moves
News

Thermo Fisher Scientific shares are lower amid intensified skepticism about growth potential and declining margins. Broader market dynamics also show modest declines.

2026. g. 13. aug. 20:06 UTC

Thermo Fisher Scientific Inc shares declined during Thursday's session, reflecting broader market trends amid rising initial jobless claims in the U.S.

2026. g. 12. aug. 22:31 UTC

Thermo Fisher Scientific Inc shares are lower in after-market hours, following a decline from Wednesday's close amid weaker overall market conditions.

2026. g. 10. aug. 20:06 UTC

News

Thermo Fisher Scientific shares are higher today after insider Britt Lisa P. exercised options for 5,850 shares at $309.63, signaling confidence in the company.

2026. g. 7. aug. 23:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline.

2026. g. 6. aug. 19:46 UTC

Thermo Fisher Scientific Inc. shares are lower today, retracing from an earlier peak amid broader market influences from rising crude oil prices and Treasury yields.

2026. g. 5. aug. 19:56 UTC

Correlated Moves
News

Stifel raised its price target on Thermo Fisher Scientific to $650, boosting investor sentiment as shares trade higher. Charles River's strong performance may also influence results.

2026. g. 4. aug. 19:36 UTC

News
Correlated Moves

Thermo Fisher Scientific shares are lower amid concerns over organic revenue growth and declining margins, compounded by negative economic data and Bruker Corp's significant drop.

2026. g. 3. aug. 19:26 UTC

Thermo Fisher Scientific Inc. shares are higher today, tracking broader market gains amid falling energy prices and renewed investor confidence. No specific company news identified.

2026. g. 1. aug. 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

2026. g. 31. jūl. 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

2026. g. 30. jūl. 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

2026. g. 29. jūl. 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

2026. g. 28. jūl. 18:06 UTC

News
Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

2026. g. 27. jūl. 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

2026. g. 24. jūl. 19:23 UTC

News
Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

2026. g. 23. jūl. 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

2026. g. 22. jūl. 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

2026. g. 21. jūl. 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

2026. g. 20. jūl. 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Salīdzinājums

Cenas izmaiņa

Thermo Fisher Scientific Inc Prognoze

Cenas mērķis

By TipRanks

-1.89% uz leju

Prognoze 12 mēnešiem

Vidējais 617.35 USD  -1.89%

Augstākais 690 USD

Zemākais 520 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Thermo Fisher Scientific Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

14

Pirkt

4

Turēt

0

Pārdot

Noskaņojums

By Acuity

65 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat